International PhD Program in Molecular Technologies and Systems Medicine

The next PhD Program of CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna will start in October 2019. We are offering 15 fully funded PhD positions atCeMM and LBI-RUD and are looking for exceptionally motivated candidates!
Medics, Biologists, Chemists, Bio­informaticians, Computer Scientists, Engineers, Physicists, Mathematicians, and candidates with a degree in a ­similar ­subject please apply now.

International PhD Program in Molecular Technologies and Systems Medicine

• Do you want to work in an environment that promotes free-minded scientific creativity, and translate your findings to impact medical practice and improve healthcare?
• Are you excited to gain a new understanding of the molecular physiology and pathology of humans?
• Do you want to join an international group of highly collaborative and successful colleagues that help you achieve your training and research goals?
• Are you a person who enjoys teamwork across disciplines and within a broader cultural and social context?
  

If yes, apply now for one of our 15 fully funded PhD positions. The next PhD Program at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of ­Sciences, and LBI-RUD, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases in Vienna will start in October 2019.

The host and partner institutes

CeMM and LBI-RUD are partner institutes and have identical principles of excellence, competitiveness, internationality as well as mentoring and training, and both operate in a unique mode of super-cooperation, connecting ­biology with medicine, experiments with computation, discovery with translation, and science with society and the arts.

The mission of CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences is to achieve maximum scientific innovation in molecular medicine to improve healthcare. At CeMM, an international and creative team of scientists and medical doctors pursues free-minded, basic life science research in a large and vibrant hospital environment of out­standing medical tradition and practice. CeMM’s research is based on post-genomic technologies and focuses on societally important diseases, such as immune disorders and infections, cancer and metabolic disorders. The goal of CeMM is to pioneer the science that nurtures the precise, personalized, predictive and preventive medicine of the future. CeMM is part of EU-LIFE an alliance of 13 top research centers in life sciences to support and strengthen European research excellence.

The research focus of LBI-RUD, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases is on rare diseases of the immune system, hematopoiesis, and the nervous system, which all together account for more than 50% of all rare diseases. LBI-RUD research will not only be relevant to the affected individuals and will provide the basis for targeted therapies, but will also provide unique and novel insights into human biology far beyond the ­specific disease, which will add to our understanding of much more frequent diseases. LBI-RUD is highly connected in global networks to promote cooperation and synergy between different disciplines and to engage rare disease patients, and LBI-RUD also holds close ties with its partner institutions, CeMM, the Medical University of Vienna, and the Children’s Cancer Research Institute (CCRI) of the St. Anna Children’s Hospital.

CeMM and LBI-RUD are located in the very same research building at the center of one of the largest medical campuses in Europe, within ­walking distance of Vienna’s historical city center. Vienna is repeatedly ranked as the world’s best city to live in and is a United Nations city with a large
international, ­English-speaking community. The official language at CeMM is English, and more than 40 different nationalities are currently represented at the institutes.